Publications

Fillos D, Scott LLF, Anderle De Sylor M, Grespin M, Luksemburg WJ, Finley B. 2012. PCB concentrations in shrimp from major import markets and the United States. Environ Toxicol Chem 31(5):1063–1071; doi: 10.1002/etc.1803. PMID: 22407850.

Hinerman JM, Dignam JD, Mueser T. 2012. Models for the binary complex of bacteriophage T4 Gp59 helicase loading protein: G32 single-stranded DNA-binding protein and ternary complex with pseudo-Y junction DNA. J Biol Chem 287(22):8608–8617; doi: 10.1074/jbc.M111.333476. PMID: 22493434.

Mease K, Sane RS, Podila L, Taub ME. 2012. Differential selectivity of efflux transporter inhibitors in Caco-2 and MDCK-MDR1 monolayers: A strategy to assess the interaction of a new chemical entity with P-gp, BCRP and MRP2. J Pharm Sci 101(5):1888–1897; doi: 10.1002/jps.23069. PMID: 22359351.

Maier A, Kohrman-Vincent M, Hertzberg R, Allen B, Haber LT, Dourson M. 2012. Critical review of dose-response options for F344 rat mammary tumors for acrylamide – Additional insights based on mode of action. Food Chem Toxicol 50(5):1763–1776; doi: 10.1016/j.fct.2012.02.002. PMID: 22366097.

Meddings J, Reichert H, Rogers MAM, Hofer TP, McMahon L. Adjusting for patients’ clinical risk of urinary tract infections: A necessary step in pay-for-performance when comparing by hospital-acquired complication rates. Presented at the 2012 Society of General Internal Medicine Annual Meeting, Orlando, FL, May 2012.

Meddings J, Reichert H, McMahon L. Hospital report cards for hospital-acquired pressure ulcers: How good are the grades? Presented at the 2012 Society of General Internal Medicine Annual Meeting, Orlando, FL, May 2012.

Wang A, Halbert RJ, Baerwaldt T, Nordyke RJ. 2012. U.S. payer perspectives on evidence for formulary decision-making. J Oncol Pract 8(3 Suppl):22s-27s; doi: 10.1200/JOP.2011.000526. PMID: 22942820.

Meddings J, Reichert H, Rogers MAM, Iwashyna TJ, McMahon L. Hospitals reporting better adherence to perioperative blood clot prophylaxis do not report lower rates of hospital-acquired post-operative blood clots. Presented at the 2012 Society of General Internal Medicine Annual Meeting, Orlando, FL, May 9-12, 2012.

Dobo KL, Greene N, Fred C, Glowienke S, Harvey JS, Hasselgren C, Jolly R, Kenyon MO, et al. 2012. In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: An industry survey. Regul Toxicol Pharmacol 62(3):449-455; doi: 10.1016/j.yrtph.2012.01.007. PMID: 22321701.

Racz L, Muller JG, Goel RK. 2012. Fate of selected estrogens in two laboratory scale sequencing batch reactors fed with different organic carbon sources. Bioresource Technol 110(April):35–41; doi: 10.1016/j.biortech.2012.01.059. PMID: 22382291.

Henderson RG, Durando J, Oller A, Merkel DJ, Marone PA, Bates HK. 2012. Acute oral toxicity of nickel compounds. Regul Toxicol Pharmacol 62(3):425-432; doi: 10.1016/j.yrtph.2012.02.002. PMID: 22333739.

Hitchcock KM, Panko JM, Scott PK. 2012. Incorporating chemical footprint reporting into social responsibility reporting. Integr Environ Assess Manag 8(2):386–388; doi: 10.1002/ieam.1288. PMID: 22431357.

Barlow CA, Sahmel J, Madl AK, Donovan BL, Gaffney SH, Burns AM, Lee RJ, Van Orden D, Paustenbach DJ. Evaluation of chrysotile adherence to clothing exposed to known airborne asbestos concentrations and subsequent to vigorous shaking. International Society of Exposure Science (ISES) 22nd Annual Meeting, Seattle, WA, 2012.

Kung MH, Yukata K, O’Keefe RJ, Zuscik MJ. 2012. Aryl hydrocarbon receptor-mediated impairment of chondrogenesis and fracture healing by cigarette smoke and benzo(a)pyrene. J Cell Physiol 227(3):1062-70; doi: 10.1002/jcp.22819. PMID: 21567390.

Thompson CM, Proctor DM, Harris MA. 2012. Duodenal GSH/GSSG ratios in mice following oral exposure to Cr(VI). Toxicol Sci 126(1):287-288; doi: 10.1093/toxsci/kfr337.

Harris MA, Thompson CM, Wolf JC, Fedorov Y, Hixon JG, Proctor DM, Suh M, Haws LC. Assessment of genotoxic potential of Cr(VI) in the intestine via in vivo intestinal micronucleus assay and in vitro high content analysis in differentiated and undifferentiated caco-2. Presented at Society of Toxicology 51st Annual Meeting, San Francisco, CA, March 2012.

Haws L, Fitzgerald L, Burkhalter K, Wikoff D. US EPA’s proposed toxicity values for TCDD: Implications for decision-making regarding the safety of foods in the United States. Presented at Society of Toxicology 51st Annual Meeting, San Francisco, CA, March 2012.

Hays SM, Kirman C, Aylward L, Suh M, Proctor D. Gastric reduction of Cr(VI) in mice, rats and humans. Presented at Society of Toxicology 51st Annual Meeting, San Francisco, CA, March 2012.

Kim S, Kopec A, Forgacs AL, Thompson CM, Zacharewski T. Genome-wide gene expression analysis of Cr(VI) effects in Fisher rat small intestinal epithelium. Presented at Society of Toxicology 51st Annual Meeting, San Francisco, CA, March 2012.

Kirman CR, Hays SM, Aylward LL, Suh M, Proctor D. 2012. Physiologically-based pharmacokinetic model for mice, rats and humans orally-exposed to chromium. Presented at Society of Toxicology 51st Annual Meeting, San Francisco, CA, March 2012.